Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer (Q79378900)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

cervix uterine cancer

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Mark H Einstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Akiva P Novetsky

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Madhur Garg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Susan M Hailpern

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Arielle Glueck

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Abbie L Fields

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Shalom Kalnicki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Gary L Goldberg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

48-53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22369

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22369

7 January 2021

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22369

7 January 2021

Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22369

7 January 2021

Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22369

7 January 2021

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22369

7 January 2021

Combined-modality therapy of locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22369

7 January 2021

Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22369

7 January 2021

Analysis of multiple prognostic factors in patients with stage IB cervical cancer: age as a major determinant

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22369

7 January 2021

Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22369

7 January 2021

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22369

7 January 2021

Biological basis for the interaction of chemotherapeutic agents and radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22369

7 January 2021

Dose intensity for bolus versus infusion chemotherapy administration: review of the literature for 27 anti-neoplastic agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22369

7 January 2021

Identifiers

DOI

10.1002/CNCR.22369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123270%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference